Why Quest Diagnostics Incorporated (NYSE:DGX) Is In News?


Thomson Reuters, a distinguished brokerage company, has placed a 52-week price target of $82.50 on Quest Diagnostics Incorporated (NYSE:DGX) shares after it surveyed top market analysts. Calculating estimated earnings after taking into consideration different elements, it is predicted to come at $5.11 for the next fiscal and $N/A for underway quarter. Valuation Estimates Analysts take into account the price to earnings ratio to estimate the firm’s valuation. This ratio, which is also called as the P/E ratio evaluates the company on relative expense factor. The formula to calculate ratio is stock’s latest price/ per share earnings. The P/E ratio of Quest Diagnostics Incorporated (NYSE:DGX) stands at 14.86. Analysts also work out Price/Earnings Growth ratio in an attempt to estimate the valuation of a firm. This ratio commonly known as the PEG ratio implies the stock’s valuation compared to earnings growth potential. Investors look to invest in the stocks with a lower PEG ratio. For Quest Diagnostics Incorporated , the PEG ratio for coming 3-5 years is 2.16. Technical Analysis The technical analysis highlights that Quest Diagnostics Incorporated current price is trading $3.75 points away +4.61% from $81.39, which stands as the 50-day moving average of the firm. The stock’s 200-day MA is $73.73 and, for now, the stock price is trading $11.41 or +15.48% away from that point. The 52-week high of Quest Diagnostics Incorporated (NYSE:DGX) was $86.85 while lowest point recorded in 52-week was $59.66. It implies if stock price makes a movement of over $-1.71, it will record a new 52-week high. In the case of $+42.71% points drop, it will touch a new 52-week low.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 10 times, 1 visits today)